Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
43.15 USD | -1.57% | +8.12% | +16.75% |
07.05. | Halozyme Therapeutics Q1 Non-GAAP-Gewinn, Umsatzanstieg; Prognose für 2024 bekräftigt | MT |
07.05. | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Filter: Derivate
Börse
Nordamerika
Südamerika
Europa
Afrika
Mittlerer Osten
Asien
Ozeanien
Mittelamerika
Emittent
Produkttyp
Typ
Fälligkeit
Nur für Hebelprodukte verfügbar
Hebel / Elastizität
Derivate
WKN | Typ | Basispreis | Fälligkeit | Elastizität | Delta | Parität | Kurs | Emittent | ||
---|---|---|---|---|---|---|---|---|---|---|
CALL
| CALL | 65 € | 21.03.2025 | 2.95x | 0.412 | 10 | 0.26 EUR |
J.P. Morgan
| ||
CALL
| CALL | 60 € | 20.09.2024 | 6.01x | 0.226 | 10 | 0.148 EUR |
Morgan Stanley
| ||
CALL
| CALL | 60 € | 20.12.2024 | 4.95x | 0.287 | 10 | 0.226 EUR |
Morgan Stanley
| ||
CALL
| CALL | 60 € | 20.12.2024 | 3.47x | 0.39 | 10 | 0.24 EUR |
J.P. Morgan
| ||
CALL
| CALL | 60 € | 21.03.2025 | 4.2x | 0.344 | 10 | 0.33 EUR |
Morgan Stanley
| ||
CALL
| CALL | 60 € | 21.03.2025 | 2.86x | 0.457 | 10 | 0.34 EUR |
J.P. Morgan
| ||
CALL
| CALL | 57.5 € | 21.06.2024 | 7.77x | 0.182 | 10 | 0.09 EUR |
Morgan Stanley
| ||
CALL
| CALL | 57.5 € | 20.12.2024 | 3.41x | 0.418 | 10 | 0.27 EUR |
J.P. Morgan
| ||
CALL
| CALL | 57.5 € | 20.09.2024 | 5.01x | 0.302 | 10 | 0.11 EUR |
J.P. Morgan
| ||
CALL
| CALL | 57.5 € | 21.03.2025 | 2.78x | 0.485 | 10 | 0.38 EUR |
J.P. Morgan
| ||
CALL
| CALL | 55 € | 21.06.2024 | 8.25x | 0.198 | 10 | 0.091 EUR |
Morgan Stanley
| ||
CALL
| CALL | 55 € | 20.09.2024 | 6.17x | 0.28 | 10 | 0.183 EUR |
Morgan Stanley
| ||
CALL
| CALL | 55 € | 21.06.2024 | 8.31x | 0.196 | 10 | 0.038 EUR |
J.P. Morgan
| ||
CALL
| CALL | 55 € | 20.12.2024 | 3.33x | 0.449 | 10 | 0.32 EUR |
J.P. Morgan
| ||
CALL
| CALL | 55 € | 20.09.2024 | 4.87x | 0.34 | 10 | 0.16 EUR |
J.P. Morgan
| ||
CALL
| CALL | 55 € | 21.03.2025 | 2.7x | 0.513 | 10 | 0.44 EUR |
J.P. Morgan
| ||
CALL
| CALL | 55 € | 21.03.2025 | 4.07x | 0.406 | 10 | 0.4 EUR |
Morgan Stanley
| ||
CALL
| CALL | 55 € | 20.12.2024 | 4.86x | 0.352 | 10 | 0.28 EUR |
Morgan Stanley
| ||
CALL
| CALL | 52.5 € | 21.06.2024 | 8.9x | 0.221 | 10 | 0.094 EUR |
Morgan Stanley
| ||
CALL
| CALL | 52.5 € | 21.06.2024 | 8.66x | 0.227 | 10 | 0.055 EUR |
J.P. Morgan
| ||
CALL
| CALL | 52.5 € | 20.09.2024 | 6.12x | 0.322 | 10 | 0.213 EUR |
Morgan Stanley
| ||
CALL
| CALL | 52.5 € | 20.12.2024 | 3.23x | 0.484 | 10 | 0.38 EUR |
J.P. Morgan
| ||
CALL
| CALL | 52.5 € | 20.09.2024 | 5.18x | 0.362 | 10 | 0.22 EUR |
J.P. Morgan
| ||
CALL
| CALL | 52.5 € | 20.12.2024 | 4.73x | 0.399 | 10 | 0.33 EUR |
Morgan Stanley
| ||
CALL
| CALL | 52.5 € | 21.03.2025 | 2.64x | 0.541 | 10 | 0.51 EUR |
J.P. Morgan
| ||
CALL
| CALL | 52.5 € | 21.03.2025 | 3.91x | 0.449 | 10 | 0.46 EUR |
Morgan Stanley
| ||
CALL
| CALL | 50 € | 21.06.2024 | 9.53x | 0.259 | 10 | 0.105 EUR |
Morgan Stanley
| ||
CALL
| CALL | 50 € | 20.09.2024 | 6.01x | 0.375 | 10 | 0.25 EUR |
Morgan Stanley
| ||
CALL
| CALL | 50 € | 21.06.2024 | 8.77x | 0.278 | 10 | 0.087 EUR |
J.P. Morgan
| ||
CALL
| CALL | 50 € | 20.12.2024 | 3.12x | 0.521 | 10 | 0.45 EUR |
J.P. Morgan
| ||
CALL
| CALL | 50 € | 20.12.2024 | 4.49x | 0.448 | 10 | 0.39 EUR |
Morgan Stanley
| ||
CALL
| CALL | 50 € | 20.09.2024 | 4.82x | 0.421 | 10 | 0.29 EUR |
J.P. Morgan
| ||
CALL
| CALL | 50 € | 21.03.2025 | 3.74x | 0.494 | 10 | 0.52 EUR |
Morgan Stanley
| ||
CALL
| CALL | 50 € | 21.03.2025 | 2.55x | 0.572 | 10 | 0.59 EUR |
J.P. Morgan
| ||
CALL
| CALL | 47.5 € | 21.06.2024 | 9.77x | 0.329 | 10 | 0.133 EUR |
Morgan Stanley
| ||
CALL
| CALL | 47.5 € | 20.09.2024 | 5.72x | 0.443 | 10 | 0.34 EUR |
Morgan Stanley
| ||
CALL
| CALL | 47.5 € | 21.06.2024 | 9.13x | 0.342 | 10 | 0.15 EUR |
J.P. Morgan
| ||
CALL
| CALL | 47.5 € | 20.12.2024 | 3.34x | 0.542 | 10 | 0.54 EUR |
J.P. Morgan
| ||
CALL
| CALL | 47.5 € | 20.12.2024 | 4.22x | 0.505 | 10 | 0.47 EUR |
Morgan Stanley
| ||
CALL
| CALL | 47.5 € | 20.09.2024 | 4.49x | 0.482 | 10 | 0.38 EUR |
J.P. Morgan
| ||
- Börse
- Aktien
- A0DLHS Aktie
- Derivate Halozyme Therapeutics, Inc.
- Optionsscheine